Related Articles
Squalene epoxidase expression is associated with breast tumor progression and with a poor prognosis in breast cancer
CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer
Rab22a is a novel prognostic marker for cell progression in breast cancer Corrigendum in /10.3892/ijmm.2021.4851
Forkhead box F1 functions as a novel prognostic biomarker and induces caspase‑dependent apoptosis in bladder cancer
HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer